Abionyx Pharma and Lille University Hospital Study CER-001 for Severe Burns
Abionyx Pharma is researching the potential of CER-001 for treating severe burns with Lille University Hospital.
Related stories
European session market picture: S&P 500 -0.09%, Nasdaq 100 -0.16%; EUR/USD +0.45%, WTI +0.07%
European session market picture. US index futures: S and P futures is down 0.09 percent, Nasdaq futures is down 0.16 percent, Dow futures is up 0.27 percent and Russell futures is
M impact | EQUITY | Nov 04, 2026, 08:00 AM UTC
Heidelberg Materials lifts Q3 revenue 10%, confirms 2026 outlook
M impact | EQUITY | Nov 04, 2026, 07:59 AM UTC
SMS Pharmaceuticals Reports Q2 Consolidated Net Profit of INR 398.5 Million
M impact | EQUITY | Nov 04, 2026, 07:59 AM UTC
SMS Pharmaceuticals Reports Q2 Consolidated Revenue of INR 3,160.9 Million
M impact | EQUITY | Nov 04, 2026, 07:59 AM UTC
APTECH Receives Contract Worth 12.4 Million Rupees
M impact | EQUITY | Nov 04, 2026, 07:59 AM UTC
Silvercorp Raises El Domo Construction Budget to $298.2 Million
M impact | EQUITY | Nov 04, 2026, 07:58 AM UTC